Evidence map›Paper›PMID 36940944›Full record

ArticleBMJ open2023

Students' and staffs' views and experiences of asymptomatic testing on a university campus during the COVID-19 pandemic in Scotland: a mixed methods study.

Linda Bauld, Alice Street, Roxanne Connelly, Imogen Bevan, Yazmin Morlet Corti, Mats Stage Baxter, Helen R Stagg, Sarah Christison, Tamara Mulherin, Lesley Sinclair and 1 more

Full text read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Linda BauldUsher Institute, The University of Edinburgh, Edinburgh, UK Linda.Bauld@ed.ac.uk.ORCID 0000-0001-7411-4260
Alice StreetSchool of Social and Political Science, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0001-7874-0234
Roxanne ConnellySchool of Social and Political Science, The University of Edinburgh, Edinburgh, UK.
Imogen BevanSchool of Social and Political Science, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-1835-4141
Yazmin Morlet CortiSchool of Social and Political Science, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-0168-3320
Mats Stage BaxterUsher Institute, The University of Edinburgh, Edinburgh, UK.
Helen R StaggUsher Institute, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-4022-3447
Sarah ChristisonSchool of Social and Political Science, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-5825-7277
Tamara MulherinUsher Institute, The University of Edinburgh, Edinburgh, UK.
Lesley SinclairDepartment of Health Sciences, University of York, York, UK.
Tim AitmanInstitute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-7875-4502

Funding

Medical Research Council MR/W006243/1
6 · The paper itself

Abstract

objectivesTo explore the acceptability of regular asymptomatic testing for SARS-CoV-2 on a university campus using saliva sampling for PCR analysis and the barriers and facilitators to participation.

designCross-sectional surveys and qualitative semistructured interviews.

settingEdinburgh, Scotland.

participantsUniversity staff and students who had registered for the testing programme (TestEd) and provided at least one sample.

results522 participants completed a pilot survey in April 2021 and 1750 completed the main survey (November 2021). 48 staff and students who consented to be contacted for interview took part in the qualitative research. Participants were positive about their experience with TestEd with 94% describing it as 'excellent' or 'good'. Facilitators to participation included multiple testing sites on campus, ease of providing saliva samples compared with nasopharyngeal swabs, perceived accuracy compared with lateral flow devices (LFDs) and reassurance of test availability while working or studying on campus. Barriers included concerns about privacy while testing, time to and methods of receiving results compared with LFDs and concerns about insufficient uptake in the university community. There was little evidence that the availability of testing on campus changed the behaviour of participants during a period when COVID-19 restrictions were in place.

conclusionsThe provision of free asymptomatic testing for COVID-19 on a university campus was welcomed by participants and the use of saliva-based PCR testing was regarded as more comfortable and accurate than LFDs. Convenience is a key facilitator of participation in regular asymptomatic testing programmes. Availability of testing did not appear to undermine engagement with public health guidelines.

Indexed as

COVID-19COVID-19 TestingCross-Sectional StudiesHumansPandemicsSARS-CoV-2ScotlandStudentsUniversitiesCOVID-19Health policyInfection controlPUBLIC HEALTHQUALITATIVE RESEARCH

Identifiers

PMID36940944
PMCPMC10030276

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read72
identifiers read4
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.